National Vaccine Advisory Committee
Will meet June 14-15 to discuss new vaccine development and licensure, vaccine adverse events, testing, post-marketing surveillance, the 1990 National Vaccine Report to Congress and the National Vaccine Plan. Meeting begins at 9 a.m. on the first day and 8:30 a.m. on the second at HHS' Hubert Humphrey Building, Room 703A, 200 Independence Ave. S.W., Washington, D.C.
You may also be interested in...
Vacci Prep is first “supplement to establish a standard of care for consumers when preparing their immune system for vaccinations,” Dentovations says.
Effective medical device regulation supports both safety and innovation needs. This article assesses how well the US FDA and the Australian TGA achieve this balance.